A detailed history of Crossmark Global Holdings, Inc. transactions in Penumbra Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 2,960 shares of PEN stock, worth $741,835. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,960
Previous 2,538 16.63%
Holding current value
$741,835
Previous $457,000 25.82%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.64 - $210.12 $69,056 - $88,670
422 Added 16.63%
2,960 $575,000
Q2 2024

Jul 29, 2024

SELL
$172.27 - $223.95 $57,538 - $74,799
-334 Reduced 11.63%
2,538 $457,000
Q1 2024

May 13, 2024

BUY
$220.09 - $273.15 $12,985 - $16,115
59 Added 2.1%
2,872 $641,000
Q4 2023

Feb 13, 2024

SELL
$181.44 - $260.22 $25,038 - $35,910
-138 Reduced 4.68%
2,813 $707,000
Q3 2023

Nov 08, 2023

SELL
$240.69 - $338.77 $24,309 - $34,215
-101 Reduced 3.31%
2,951 $687,000
Q2 2023

Jul 31, 2023

SELL
$271.54 - $344.06 $73,858 - $93,584
-272 Reduced 8.18%
3,052 $940,000
Q1 2023

May 12, 2023

BUY
$220.43 - $278.69 $43,865 - $55,459
199 Added 6.37%
3,324 $926,000
Q4 2022

Jan 19, 2023

SELL
$151.88 - $228.5 $31,439 - $47,299
-207 Reduced 6.21%
3,125 $695,000
Q3 2022

Nov 01, 2022

BUY
$120.36 - $205.88 $20,461 - $34,999
170 Added 5.38%
3,332 $632,000
Q2 2022

Jul 29, 2022

SELL
$116.09 - $227.33 $5,804 - $11,366
-50 Reduced 1.56%
3,162 $394,000
Q1 2022

May 11, 2022

SELL
$187.51 - $283.98 $7,500 - $11,359
-40 Reduced 1.23%
3,212 $714,000
Q4 2021

Jan 10, 2022

SELL
$238.08 - $288.0 $199,987 - $241,920
-840 Reduced 20.53%
3,252 $934,000
Q3 2021

Oct 21, 2021

BUY
$250.72 - $291.24 $1.03 Million - $1.19 Million
4,092 New
4,092 $1.09 Million
Q3 2021

Oct 13, 2021

SELL
$250.72 - $291.24 $1.07 Million - $1.24 Million
-4,262 Closed
0 $0
Q2 2021

Jul 21, 2021

SELL
$235.0 - $310.7 $49,350 - $65,247
-210 Reduced 4.7%
4,262 $1.17 Million
Q1 2021

Apr 15, 2021

SELL
$175.6 - $291.43 $12,292 - $20,400
-70 Reduced 1.54%
4,472 $1.21 Million
Q4 2020

Jan 14, 2021

SELL
$174.98 - $272.83 $15,748 - $24,554
-90 Reduced 1.94%
4,542 $795,000
Q3 2020

Oct 08, 2020

BUY
$185.27 - $238.73 $12,968 - $16,711
70 Added 1.53%
4,632 $900,000
Q2 2020

Aug 14, 2020

BUY
$153.32 - $191.72 $58,568 - $73,237
382 Added 9.14%
4,562 $816,000
Q1 2020

Apr 28, 2020

SELL
$124.34 - $193.76 $14,920 - $23,251
-120 Reduced 2.79%
4,180 $674,000
Q4 2019

Feb 06, 2020

SELL
$134.81 - $177.8 $25,613 - $33,782
-190 Reduced 4.23%
4,300 $706,000
Q3 2019

Oct 09, 2019

BUY
$131.82 - $183.4 $591,871 - $823,466
4,490 New
4,490 $604,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.5B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.